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Abstract 
Rat L6 myoblasts were recently shown to possess the GLUT 1, 3 and 4 transporters, and not the GLUT 2 isoform [1]. This 
investigation examined the expression and properties of the GLUT 1 isoform. GLUT 1 transcript level was significantly reduced in cells 
grown at high densities and during myogenic differentiation. A comparison of the GLUT 1 and 4 transcript levels in myogenesis-com- 
petent and impaired cells revealed an inverse relationship between these two isoforms. This relationship was confirmed by studies using 
two independent spontaneous GLUT 3-GLUT 4- mutants, M1 and M3. These mutants possessed very high level of the GLUT 1 
isoform, but negligible amount of the GLUT 3 and 4 isoforms. GLUT 1 expression was also subject to positive regulation. Glucose 
starvation was found to increase not only the levels of the GLUT 1 transcript and transporter, but also the intrinsic activity of the GLUT 1 
transporter. Studies with M1 and M3 mutants revealed that the GLUT 1 transporter was not functional in glucose-grown cells, even 
though it was present at a very high level in the plasma membrane. This transporter became functional when cells were starved for 
glucose. The functional GLUT 1 transporter had an apparent K m value of around 0.9 mM, and was sensitive to cytochalasin B, phloretin, 
phlorizin and pCMBS. 
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1. Introduction 
Considerable ffort has been focused in recent years on 
the regulatory mechanisms of glucose transport in eukary- 
otic cells. The uptake of glucose and its analogues is 
facilitated by a group of highly conserved glucose trans- 
porters (GLUT) [2-7]. Different mechanisms have been 
shown to regulate glucose transport activities. These in- 
clude: (i) altered synthesis of the GLUT isoforms brought 
about by changing the transcription rates and/or  stability 
of the mRNAs [2,8-11]; (ii) recruitment of glucose trans- 
porters from intracellular storage sites to the plasma mem- 
brane [6,12]; and (iii) modulation of the intrinsic activity of 
glucose transporter [3,6,13-20]. GLUT isoforms in the 
Abbreviations: BrdUrd, 5-bromo-2'-deoxyuridine; CB, cytochalasin 
B; dGlc, 2-deoxy-D-glucose; GLUT, glucose transporter; HAHT, high 
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pCMBS, p-chloromercuribenzenesulfonic acid; SDS, sodium dodecyl 
sulfate. 
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same cell are found to respond differently to metabolic and 
physiological changes, or upon exposure to different hor- 
mones or growth factors [1,21,22]. For example, the ex- 
pression of GLUT 1 and 4 differs considerably in insulin- 
treated or glucose-starved cells [22], as well as at different 
stages of development [23-26]. 
An examination of the regulation and properties of a 
specific GLUT isoform is complicated by the presence of 
other GLUT isoforms in the same cell. For example, at 
least two glucose transport systems exist in chicken em- 
bryo fibroblasts, rat adipocytes, rat and human myoblasts, 
human skin fibroblasts and mouse 3T3 cells [22,27-34]. 
Even though the GLUT transcript and transporter levels 
can be determined, the similarities in their transport prop- 
erties make it difficult to assess the functional state and 
kinetic property of a specific GLUT transporter. 
One recent approach to examine the properties of indi- 
vidual GLUT isoforms is to express these isoforms in 
Xenopus oocytes [35-37]. While these studies are invalu- 
able in determining the identity and general nature of the 
GLUT isoforms, they cannot provide information on the in 
situ functional states of the GLUT transporter under differ- 
ent metabolic and developmental conditions. In view of the 
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expression vectors used, this approach will not reveal how 
the expression of one GLUT isoform can be regulated by 
the presence of other GLUT isoforms. Another approach is 
to examine the properties of cell lines that possess only 
one GLUT isoform. For example, both Chinese Hamster 
Ovary (CHO) cells and mouse 3T3-L1 fibroblasts are 
found to possess only the GLUT 1 isoform [3]. However, 
these cells cannot be used to examine the influence of 
other GLUT isoforms on the expression of the GLUT 1 
isoform. 
Since most eukaryotic ells contain two or more GLUT 
isoforms, mutants possessing only one GLUT isoform can 
be used to examine the influence of other GLUT isoforms. 
A comparison of the mutant and parental properties will 
reveal not only the role(s) played by other GLUT isoforms, 
but also the in situ regulation of this particular GLUT 
isoform. More importantly, these mutants will allow an 
examination of the intrinsic property of a particular GLUT 
transporter without interference by other isoforms. The rat 
L6 myoblast system is uniquely suited for these studies. 
These cells possess the GLUT l, 3 and 4 isoforms, but not 
the GLUT 2 isoform [1]. The glucose transport property of 
L6 myoblast in whole cells and in plasma membrane 
vesicles have been characterized by kinetic analysis, cyto- 
chalasin B (CB) binding and photolabelling studies, and by 
inhibitor studies [31,38-42]. Transport, and not substrate 
phosphorylation, is the rate-limiting step in the uptake of 
dGlc by rat myoblasts, even at very high substrate concen- 
trations [31]. A high (HAHT) and a low affinity (LAHT) 
hexose transport process, as well as at least two CB 
binding sites have been detected in undifferentiated my- 
oblasts. These two transport processes are regulated iffer- 
ently during metabolic and developmental changes 
[15,43,44]. Rat myoblast mutants defective in the GLUT 3 
and/or the GLUT 4 isoforms have been isolated and 
characterized [1,44,45]. These mutants are invaluable in 
identifying the transcripts and transporters for various glu- 
cose transport processes; the GLUT 3 and 4 isoforms are 
found to be associated with the HAHT and LAHT, respec- 
tively. Studies with two independent spontaneous GLUT 
3 GLUT 4-  mutants indicated that the GLUT 1 isoform 
was the only GLUT isoform present in these cells [1]. The 
present investigation utilized these mutants to examine the 
in situ expression of the GLUT 1 isoform and its intrinsic 
activity under different growth conditions. 
were maintained in Alpha medium (Flow Laboratories) 
supplemented with 25 mM o-glucose, 10% (v/v)  horse 
serum (Flow Laboratories) and gentamycin (72 /zg/ml; 
Life Technologies) [47]. Cells cultured in this medium 
were referred to as glucose-grown cells. The glucose star- 
vation medium was Alpha medium prepared without I> 
glucose and was supplemented with 25 mM fructose and 
10% (v/v)  dialysed horse serum. 
2.2. Transport studies 
Transport studies were carried out using six-well (35 X 
15 mm) Falcon plates [15]. Cells were routinely plated at a 
density of 1.5 • 105 cells/well. After removal of medium, 
each well was washed with 10 ml of phosphate-buffered 
saline (PBS: 137 mM NaC1, 2.7 mM KCI, 8.1 mM 
Na2HPO4, 1.5 mM KH2PO4, 0.9 mM CaCI2, and 0.5 mM 
MgCI2), and replaced with 900 /zl of the uptake buffer 
(PBS containing 1 mg/ml  bovine serum albumin). Trans- 
port studies were carried out at 23 ° C and were initiated by 
adding 100 /zl of radioactive substrate to the desired final 
concentration. At appropriate times, uptake was terminated 
by rapidly washing the cells twice (less than 15 s) with 10 
ml of ice-cold PBS. In the case of MeGlc uptake, washes 
were carried out with cold PBS containing 1 mM mercuric 
chloride. Transport studies were carried out using the same 
range of substrate concentrations as in determining the 
GLUT 3 and 4 transport kinetics [31]. The initial rates of 
uptake were calculated from the amount of substrate taken 
up at 15, 30, 45 and 60 s. after addition of radioactive 
substrate. Cells were solubilized by adding 1 ml of 0.1% 
Triton X-100, and 0.8 ml aliquot was counted in 10 ml of 
scintillation fluid. Cells from two wells on each plate were 
detached with 0.1% trypsin, and the cell number was 
determined using a Coulter counter. Under our experimen- 
tal conditions, the uptake of dGlc and MeGlc was linear 
with time, and over 95% of the dGlc taken up was 
phosphorylated [31]. Even at a concentration of 10 mM, 
transport and not phosphorylation is the rate-limiting step 
in dGlc uptake. Transport studies were carried out in 
duplicate and each experiment was repeated twice. Data 
were analyzed by a linear least squares regression fit 
program (SlideWrite Plus, Advanced Graphics Software, 
Sunnyvale, CA), and by a non-linear egression data analy- 
sis program (Enzfitter program, Biosoft, Cambridge, UK). 
2. Methods and materials 
2.1. Cell lines and culture media 
Rat L6 skeletal myoblast was originally obtained from 
Yaffe [46]. Strain D23 is a spontaneous GLUT 3 GLUT 
4 + mutant isolated from rat L6 myoblast [45]. Mutants M1 
and M3 are two independent spontaneous GLUT 3-GLUT 
4-  mutants elected from D23 myoblast [1]. All cell lines 
2.3. Isolation of  mRNA from rat myoblasts 
Poly(A) + RNA was isolated irectly from rat myoblasts 
using the FastTrack TM mRNA isolation kit (Invitrogen, 
San Diego, CA), as previously described [1]. 
2.4. Preparation of  cDNA probes 
Plasmids harbouring GLUT cDNAs were purchased 
from the Repository of Human DNA Probes and Libraries, 
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American Type Culture Collection, Rockville, MD. The 
human GLUT 1 cDNA was originally provided by B. 
Thorens, Whitehead Institute for Biomedical Research, 
Cambridge, MA [48], whereas the human GLUT 3 cDNA 
was obtained from G. Bellt, Howard Hughes Medical Insti- 
tute, University of Chicago [49]. The rat GLUT 4 cDNA 
was a generous gift from M. Birnbaum, Harvard Medical 
School, Boston, MA [5011. /32-Microglobulin cDNA was 
originally obtained from F'. Daniel, Pasteur Institute, Paris, 
France [51]. Plasmid DNA was isolated by the alkaline 
lysis method [52]. Plasmid cDNA was extracted twice with 
phenol/chloroform/isoamyl alcohol (25:24:1); and once 
with chloroform/isoamyl alcohol (24:1). Different restric- 
tion enzymes were used for isolating cDNA inserts: BamHI 
for GLUT 1, SalI for GLUT 3, and EcoRI for GLUT 4. 
Plasmid DNA was incubated with the appropriate restric- 
tion enzyme for 2 h at 37 ° C. After electrophoresis through 
a 0.9% agarose gel and purification using the Gene Clean 
Kit (Bio/Can Scientific), the insert was labelled with 32p 
using the Prime-a-Gene kit (Promega). 
2.5. Northern gel blotting studies 
For RNA blotting, 2 p,g of poly(A) + RNA were dena- 
tured with formaldehyde 1153]. An RNA ladder (BRL) was 
used as the standard molecular weight marker. After sepa- 
ration by electrophoresis through an 1.2% formaldehyde 
agarose gel, the RNA was transferred to a Biotrans nylon 
membrane (ICN Biochemicals) by a vacuum blotting sys- 
tem (VacuGene TM XL, Pharmacia). The nylon membrane 
was then UV irradiated for 30 s at 1.2.10 6 /~J with the 
Stratalinker TM UV Crosslinker 1800 (Stratagene). The 
blotted and fixed membrane was prehybridized at 42 ° C for 
2-3 h in a solution containing 50% formamide, 5 × SSC, 
2 × Denhardt's olution, 20 mM sodium phosphate buffer 
(pH 6.5), 0.1% sodium dodecyl sulfate (SDS), and 100 
/zg/ml denatured herring sperm DNA [52]. Hybridization 
with the 32 P-labelled cDNA probe was carried out at 42 ° C 
overnight in the prehybridization solution containing 10% 
dextran sulfate, and 1-10 6 cpm/ml  of the 32p-labelled 
insert. The blot was then washed with 0.1 × SSC and 0.1% 
SDS first at 23 ° C for 15 min and then at 55 ° C for 20-30 
min; after which it was exposed to Kodak XAR-5 film at 
- 70 ° C for 20 h. Bands i:a the autoradiogram were quanti- 
fied using the JAVA Video Analysis Software, Jandel 
Scientific. All experiments were repeated at least twice 
with two different RNA preparations. 
2.6. Purification of plasma membrane and microsome 
Plasma membranes and microsomes were prepared from 
myoblasts as previously described [38,42,54]. Unlike most 
conventional methods [19,55,56], the crude plasma mem- 
brane obtained from differential centrifugation was further 
fractionated by centrifugation through a discontinuous su- 
crose gradient, consisting of 24, 29, 35 and 45% (w/w)  
sucrose. The plasma membrane was recovered in the 24% 
fraction and in the interface between the 24% and 29% 
fractions. Only 5% of the proteins loaded onto the sucrose 
gradient was recovered in these two fractions [38]. These 
two fractions were highly enriched in the plasma mem- 
brane marker enzyme, the ouabain-sensitive Na+/K  +- 
ATPase, and were devoid of marker enzymes for mito- 
chondria (NADH-dependent cytochrome-c reductase), mi- 
crosomes (succinate-dependent cy ochrome-c reductase), 
and cytoplasmic contents (lactate dehydrogenase and hex- 
okinase). 
2.7. Immunoblotting studies with membrane preparations 
Membrane preparations were dissolved in the SDS-sam- 
pie buffer at room temperature, and subjected to SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) using the 
discontinuous buffer system of Laemmli [57]. After elec- 
trophoresis, proteins were electrophoretically transferred 
from the gel onto nitrocellulose membranes using the 
transfer buffer (25 mM Tris, 192 mM glycine (pH 8.3), 
20% methanol, and 0.1% SDS) at 55 V for 2 h [58]. 
Non-specific protein binding was minimized by incubating 
with 20% fetal calf serum for at least 5 h at 23 ° C in a Tris 
buffer containing 150 mM NaC1, 10 mM Tris-HCl (pH 
8.0), and 0.05% Tween 20. The membrane was washed 
once with the same Tris buffer, and was then incubated 
with anti-rat GLUT 1, anti-mouse GLUT 3 or anti-rat 
GLUT 4 antibodies (East Acres Biologicals, Southbridge, 
MA) for 14 h at 23 ° C. After washing with the same Tris 
buffer three times (5-10 min for each wash), the mem- 
brane was incubated with a25I-protein A for 4 h. The 
unbound 125I-protein A was removed by washing three 
times with the Tris buffer, blots were dried and exposed to 
Kodak X-Omat film at -86  ° C. After identifying the 
GLUT 1 transporter band on the autoradiogram, the corre- 
sponding spot on the nitrocellulose paper was cut and 
counted in a y-counter. Specific binding was determined 
by subtracting background radioactivity present on a size- 
matched strip of the filter paper cut out from an area next 
to the GLUT 1 band on the same lane. Experiments were 
repeated at least twice. 
2.8. Determination of fusion index 
On different days after subculturing, cells were treated 
with 1 mM ZnSO 4 in 20% DMSO to swell the nuclei and 
fixed in 2.5% glutaraldehyde in PBS, and then stained with 
6% Giemsa [43]. Fusion index was calculated as the 
percentage of total nuclei present in myotubes [44,59]. 
Only structures containing at least three nuclei were con- 
sidered as myotubes. Usually each field contained at least 
50 nuclei. Ten fields were counted for each set of determi- 
nations. 
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2.9. Materials A 
2-Deoxy-o-[1,2-3H]glucose (50 Ci /mmol)  and 3-0- 
[methyl-3H]methyl-o-glucose (50 Ci /mmol)  were pur- 
chased from ICN Biochemicals. [a-32p]dCTP and 1251- 
labeled protein A were from Amersham Canada. Restric- 
tion enzymes, Prime-a-Gene kit, and molecular weight 
markers were purchased from Promega. Cytochalasin B, 
pCMBS, phloretin, phlorizin and 5-bromo-2'-deoxyuridine 
were purchased from Sigma. All other chemicals were 
purchased from commercial sources and were of the high- 
est available purity. 
3.  Resu l ts  
3.1. Negative regulation of  GLUT 1 expression in rat 
myoblasts 
Poly(A) ÷ RNAs from myogenesis-competent L6 cells 
were used to examine the expression of the GLUT 1 
isoform during myogenesis. A 10% drop of the GLUT 1 
transcript level was observed between days 3 and 4; 
whereas a 40% drop occurred between days 4 and 5. Thus, 
dramatic reduction of the GLUT 1 transcript was observed 
only upon appearance of multinucleated myotubes (i.e., 
after day 4) (Fig. 1). This was distinct from the uniform 
rate of decline observed for the GLUT 3 transcript from 
day 2 to day 6 [1]. 
To determine the relationship between the decline in the 
GLUT 1 transcript and myogenesis, poly(A) ÷ RNAs were 
prepared from L6 cells treated with myogenesis inhibitors, 
such as 5'-bromo-2-deoxyuridine or phloretin [44,60]. The 
GLUT 1 transcript level was reduced at a much slower rate 
in myogenesis-impaired c lls than that in myogenesis-com- 
petent cells (Fig. 1). When compared with day 2 cultures, 
the GLUT 1 transcript was reduced by 30% and 60% in 
day 5 culture of the myogenesis-impaired and competent 
cells, respectively. Thus, GLUT 1 expression was affected, 
directly or indirectly, by events associated with myogene- 
sis. 
A comparison of the GLUT transcript levels during 
myogenesis revealed that multinucleated myotubes (day 6 
culture) possessed about 25% (Fig. 1) and 7500% [1] of 
the day 2 GLUT 1 and 4 transcript levels, respectively. 
Such an inverse relationship between GLUT 1 and 4 
expression was also observed in myogenesis-impaired c lls. 
Day 5 culture of phloretin-treated cells harboured 70% and 
200% of the day 2 GLUT 1 and GLUT 4 transcript levels, 
respectively (Fig. 1, [1]). More interestingly, while the 
GLUT 4 transcript level was elevated at an uniform rate 
during myogenesis [1], dramatic decreases in the GLUT 1 
transcript (between day 4 and 5) (Fig. 1) occurred only 
after a 4-fold increase in the GLUT 4 transcript (day 3.5) 
[1]. Thus, similar to adipose tissues [61], increases in the 
GLUT 4 transcript preceded the major decline of the 
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Fig. 1. Reduced levels of the GLUT 1 transcript during myogenesis and 
in confluent cultures. Poly(A) ÷ RNAs were prepared from rat L6 my- 
oblasts grown under different physiological conditions. Northern blot 
studies were carried out with labelled GLUT 1 and fl2-microglobulin 
cDNAs. Panel A is an autoradiogram showing the GLUT 1 transcript 
level of untreated L6 cells at different stages of myogenesis. Panel B 
shows the GLUT 1 transcript levels in myogenesis-competent and im- 
paired cells. Rat L6 myoblasts were grown in the presence orabsence of
myogenesis inhibitors. The bands in the autoradiogram were quantified 
by using the JAVA Video Analysis Software, Jandel Scientific. The 
GLUT 1 transcript level in each culture was normalized according tothe 
amount of the flz-microglobulin mRNA present in each preparation. The 
GLUT 1 transcript level present inday 2 cultures was taken as 100%. O, 
A, and ,7 denote the GLUT 1 transcript levels in untreated, phloretin (50 
/xM)- and BrdUrd (7.5 /zM)-treated L6 myoblasts, respectively. This 
figure shows the result of three separate experiments u ing two separate 
mRNA preparations. Fusion indices (+) of untreated L6 cells were 
determined aspreviously described [44]. 
GLUT 1 transcript. In other words, GLUT 1 expression 
might be negatively regulated by the GLUT 4 isoform. 
GLUT 1 expression was also examined in day 2 cul- 
tures seeded at different densities. When compared with 
cultures eeded with 0.2 • 102 cel ls/cm 2, about 26%, 50% 
and 60% reduction in the GLUT 1 transcript level were 
observed in day 2 cultures seeded with 0.3 • 10 a, 0.4.102 
and 0.8.102 cel ls/cm 2, respectively. Thus, similar to 
GLUT 3 and 4 transcripts [1], GLUT 1 transcript level was 
reduced in confluent cultures. The reduction of all three 
GLUT transcripts indicated that a mechanism different 
from that associated with the above-mentioned GLUT 4 
effect was probably involved. 
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3.2. GLUT 1 expression itI GLUT 3 -GLUT 4 - mutants 
To further explore the relationship between the GLUT 1 
and 4 expression, GLUT 1 transcript levels in several 
isogenic rat myoblast cell lines, L6, D23, M1 and M3, 
were examined. GLUT 1 transcript level in glucose-grown 
M1 and M3 mutants was twice that present in L6 cells 
(Table 1). Similar increase in the GLUT 1 transcript level 
was also observed in glucose-starved M1 and M3 mutants. 
It was important o note that such an increase was not 
observed with the parental GLUT 4 ÷ D23 cells. This 
suggested that the increase in the GLUT 1 transcript level 
was associated with the defect in the GLUT 4 isoform. 
This is the first genetic evidence indicating the inverse 
relationship between the expression of the GLUT 1 and 4 
isoforms. 
3.3. Positice regulation of GLUT 1 expression in rat 
myoblasts 
muir±nucleated ratL6 myotubes [2,18,22], only the expres- 
sion of the GLUT 1 isoform in mononucleated rat L6 
myoblasts was positively regulated by events associated 
with glucose starvation. 
To gain further insight into the regulatory mechanisms 
involved, the response of GLUT 4- mutants to glucose 
starvation was examined. The GLUT 1 transcript levels in 
glucose-starved L6, D23, M1, and M3 cells were 217%, 
175%, 173% and 184% of those present in their glucose- 
grown counterparts, respectively (Table 1). Thus, despite 
their defect in the GLUT 3 and/or GLUT 4 isoform, 
similar increases were observed in all the strains tested. If 
the GLUT cDNAs bind with their respective transcripts 
with similar efficiencies, a calculation based on data pre- 
sented in Fig. 2B and Table 1 revealed that the GLUT 1 
transcript level was about 1400% higher than the GLUT 3 
and 4 transcript levels in glucose-starved M1 and M3 
mutants. In other words, the GLUT 1 transcript is the 
predominant GLUT transcript present in these mutants. 
We have previously demonstrated that glucose-starved 
(i.e., fructose-grown) myoblasts exhibit much higher glu- 
cose transport and CB-binding activities than their glu- 
cose-grown counterparts I]15,40,41]. Since three different 
GLUT isoforms are present in rat L6 myoblasts [1], it is 
important to determine which GLUT isoform(s) are altered 
in glucose-starved cells. In this study, poly(A) ÷ RNAs 
from day 2 cultures of glucose-grown and starved L6 
myoblasts were probed with similar amounts of 32p_ 
labelled GLUT 1, 3, and 4 cDNAs (Fig. 2). Transcript 
levels were determined by the amount of cDNA bound to 
different amounts of the same transcript. Even though 
GLUT 1 was the least abundant GLUT transcript in glu- 
cose-grown cells (Fig. 2A), it was the most abundant one 
in glucose-starved cells (Fig. 2B). On the other hand, 
GLUT 3 and 4 transcript levels were not significantly 
altered by glucose starvation (Table 1). Thus, similar to 
3.4. Amount and subcellular distribution of the GLUT 1 
transporter in carious cell types 
To examine the amount and subcellular distribution of 
the GLUT 1 transporter in various mutants, immuno- 
blotting studies were carried out using saturating amount 
of the rabbit anti-GLUT 1 Ab (East Acres Biologicals, 
Southbridge, MA), and 125I-protein A (Fig. 3, Table 2). 
Highly purified plasma membranes and microsomes were 
used in this investigation (see Methods and materials for 
properties). Since the GLUT 1 transporter level in D23 
plasma membrane has been determined by CB binding 
studies [1,40], the GLUT 1 transporter content in other 
membrane preparations can be calculated by determining 
the amount of a25I-protein A bound to the GLUT 1 im- 
muno-complex associated with the D23 and other mem- 
brane preparations. 
Table 1 
Transcript levels of glucose transporters in glucose-grown and glucose-starved mutants 
Carbon source L6 (HAHT + LAHT + ) D23 (HAHT- LAHT + ) M1 (HAHT- LAHT- ) M3 (HAHT- LAHT- ) 
GLUT 1 transcript (2.8 kb) 
Glucose 100 113 + 26.9 191 + 11.1 196 + 24 
Fructose 217 ± 9.2 198 + 34.5 331 + 18.9 360 + 42.1 
GLUT 3 transcript (4.1 kb) 
Glucose 100 16 + 4.0 12 + 1.4 16 + 3.5 
Fructose 85 ± 5.6 11 + 2.8 15 + 8.7 15 + 9.2 
GLUT 4 transcript (2.8 kb) 
Glucose 100 107_+ 3.5 22 + 8.4 28 + 8.2 
Fructose 102 ± 0 95 ± 3.2 22 + 2.6 30 + 7.2 
Transcript levels for various glucose transporters were determined by Northern blot analysis. PoIy(A) ÷ RNAs were extracted from day 2 cultures of 
glucose-grown and fructose-grown (i.e., glucose-starved) L6, D23, M1, and M3 myoblasts. Labelled full length human erythrocyte GLUT 1, human fetal 
muscle GLUT 3, and rat insulin-responsive GLUT 4 cDNAs were used to detect he rat myoblast GLUT 1, GLUT 3 and GLUT 4 transcripts, respectively. 
The bands in the autoradiograms were quantified using the JAVA Video Analysis Software, Jandel Scientific. The GLUT transcripts in each culture were 
normalized according to the a~aaount of /3a-microglobulin transcript present in each preparation. For each GLUT transcript, the level present in 
glucose-grown L6 cells was taken as 100%. Data indicate the results from three separate xperiments. Transcript levels in glucose-grown L6, D23, and M1 
cells were taken from Xia et al. [1], and were included for the ease of comparison. 
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GLUT 1 transporter levels in plasma membranes from 
glucose-grown cells were first examined (Fig. 3, Table 2). 
This transporter was present in the highly purified L6 
plasma membrane at a concentration of 9.4 pmol per mg 
protein. The GLUT 1 transporter levels in D23 and M3 
plasma membrane were 18.1 and 21.5 pmol per mg pro- 
tein, respectively. A comparison with their respective 
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Fig. 3. Glucose transporter levels in plasma membranes and microsomes 
prepared from glucose-grown and starved myoblasts. Purified plasma 
membranes and microsomes were prepared from day 2 cultures of 
glucose-grown and starved myoblasts [38]. Electrophoresis and transfer 
onto nitrocellulose paper were performed as described in the text. Each 
lane was loaded with 60 /xg protein. Nitrocellulose strips were incubated 
with antibodies raised the carboxyl termini of the rat GLUT 1 trans- 
porters, mouse GLUT 3, and rat GLUT 4 (East Acres Biologicals, 
Southbridge, MA). After washing, the strips were incubated for 4 h with 
105 cpm of 125I-protein A, and air-dried and exposed to X-ray film. Panel 
A shows the GLUT 1 transporter levels in the plasma membrane and 
microsomes prepared from glucose-grown and -starved L6 (L6G and 
L6S), D23 (D23G and D23S), and M3 (M3G and M3S) cells, respec- 
tively. Panel B shows the GLUT 3 and 4 transporter levels in plasma 
membranes prepared from glucose-grown and starved L6 myoblasts (L6G 
and L6S). 
POLY (A) * RNA (pg) 
Fig. 2. Transcripts for glucose transporters in glucose-grown and -starved 
rat L6 myoblasts. Poly(A) ÷ RNA was extracted from day 2 culture of rat 
L6 myoblast grown in the presence of 25 mM D-glucose or 25 mM 
fructose. Panels A and B show the GLUT 1, 3, and 4 transcript levels in 
glucose-grown and fructose-grown (i.e., glucose-starved) cells, respec- 
tively. Radioactive GLUT 1, 3, and 4 cDNAs were used to quantify the 
amount of specific transcripts in each RNA preparation. 40 ng of each 
type of cDNAs were labelled with [ ~_32 P]dCTP by random priming 
using the Prime-a-Gene kit. Hybridization of the blot was carried out with 
2.107 cpm of the 32p-labelled cDNAs. After washing, blots were ex- 
posed to Kodak XAR-5 films at - 70 ° C for 42 h. The autoradiogram was 
used to pinpoint the location of specific transcripts on the blot. After 
cutting out the spot containing the transcript, he amount of radioactivity 
associated with this spot was determined. Background counts were deter- 
mined by the radioactivity associated with another spot of the same area 
on the same lane. After subtracting background counts, the amount of 
eDNA bound to a specific transcript was then calculated. O, A, and • 
denote the amount of specific eDNA bound to the 2.8 kb GLUT 1, 4.1 kb 
GLUT 3 and 2.8 kb GLUT 4 transcripts, respectively. 
GLUT 1 transcript levels (Table 1) revealed that the 
GLUT 1 transporter content in these two mutants was 
considerably higher than expected. The observed increases 
were not due to subcellular edistribution of the GLUT 1 
transporter, as similar increases were also observed in the 
microsomes (Table 2). This suggests that the translation 
and/or turnover rates of the GLUT 1 transporter are 
altered in the GLUT 3-  mutants, D23 and M3. 
GLUT 1 transporter levels in glucose-starved cells were 
also examined (Fig. 3, Table 2). When compared with their 
glucose-grown counterparts, plasma membranes from glu- 
cose-starved L6, D23, and M3 cells possessed an addi- 
tional 26 pmol of the GLUT 1 transporter per mg protein; 
whereas microsomes from glucose-starved cells possessed 
an additional 13 pmol of the GLUT 1 transporter per mg 
protein (Table 2). Since similar increases were observed 
with all cell types, the glucose starvation response was not 
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influenced by the GLUT 3 or 4 isoforms. It should be 
noted that the GLUT 3 and 4 transporter levels in L6 cells 
were not altered by glucose starvation (Fig. 3). 
3.5. Regulation of the functional states of the GLUT 1 
transporter 
Since GLUT 1 was the predominant GLUT transporter 
in mutants M1 and M3, these mutants could be used to 
examine the GLUT 1 transport properties free of interfer- 
ence by other GLUT isof, arms. Analysis of transport data 
by Lineweaver-Burk plot clearly indicated that the absence 
of both GLUT 3 (K  m = 0.67 mM) and GLUT 4 (K  m = 3.5 
mM) transport systems in ~:he glucose-grown mutants (open 
symbols). The activities of the residual GLUT 3 and 4 
transporters were too low to be detected. The line drawn 
by a linear least squares regression fit program extrapo- 
lated close to the origin of the plot; thus suggesting dGlc 
was taken up via a very ]Low affinity transport process or 
via simple diffusion. Tran:sport data were also analyzed by 
non-linear egression fit ~Eo the Michaelis-Menten hyper- 
bola. The apparent K m walues for glucose-grown M1 and 
M3 mutants were found to be around 114 M and 369 mM, 
respectively. In other words, these glucose-grown mutants 
exhibited extremely low transport affinity for dGlc. In 
view of their very high plasma membrane GLUT 1 trans- 
porter content (21.5 pmol per mg protein) (Table 2), these 
studies indicated that the GLUT 1 transporter was not 
functional in glucose-grown cells. 
In sharp contrast to glucose-grown cells, glucose-starved 
M1 and M3 mutants took up dGlc with an apparent K m 
value of around 0.8 mM (solid symbols in Fig. 4). A 
non-linear regression fit revealed that the apparent K m 
values for dGlc uptake by the glucose-starved M1 and M3 
mutants were 1.07 + 0.05 mM and 1.05 + 0.16 mM, re- 
spectively. Since these mutants were devoid of the GLUT 
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Fig. 4. Kinetics of 2-deoxy-D-glucose uptake by glucose-grown and 
starved M1 and M3 mutants. Transport studies were carried out with 
glucose-grown a d starved M1 and M3 mutants as described in the text. 
Initial rates of uptake were calculated from the amount of dGlc taken up 
at 23 ° C in 15, 30, 45 and 60 s. The velocity (V) is expressed as pmol of 
dGlc taken up per min per 105 cells. S refers to the concentration f dGlc 
(in mmol per 1) used. An equal amount of counts was added to each dGlc 
concentration. Data was analyzed by Lineweaver-Burk plot. • and • 
denote dGlc uptake by mutants M1 and M3, respectively. Open and solid 
symbols indicate uptake by glucose-grown a d starved cells, respectively. 
The lines through the above symbols were drawn by a linear least squares 
regression fit program (SlideWrite Plus TM, version 4.0, Advanced Graph- 
ics Software, Sunnyvale, CA). • indicates the net amount of dGlc taken 
up by the carrier-mediated transport process present in glucose-starved 
M3 cells; the amount of dGlc internalized via simple diffusion (as 
determined by the rates of dGlc uptake by CB-treated D23 cells) was 
subtracted from the raw data [1]. 
2, 3 and 4 isoforms (Table 1 and [1]), the GLUT 1 
transporter was likely responsible for this transport activ- 
ity. After correcting for diffusion, the transport capacity of 
the GLUT 1 transport process in glucose-starved M3 cells 
Table 2 
GLUT 1 transporter levels in the plasma membrane and microsome of glucose-grown a d starved mutants 
Plasma membrane Microsome 
glucose-grown glucose-starved starvation- glucose-grown glucose-starved starvation- 
cells cells stimulated increase cells cells stimulated increase 
L6 Protein A bound a 32.3 127.5 95.2 8.3 56.3 48.0 
CB bound b 9.4 37.0 27.6 2.4 16.4 14.0 
D23 Protein A bound 62.3 163.3 101.0 26.7 71.2 44.5 
CB bound 18.1 47.4 29.3 7.7 20.7 13.0 
M3 Protein A bound 74.0 151.7 77.7 28.8 75.5 46.7 
CB bound 2L5 44.0 22.5 8.4 21.9 13.5 
a The amount of protein A bound is expressed as pg of protein A bound per mg protein. 
h The amount of cytochalasin B (CB) bound is expressed as pmol of CB bound per mg protein. 
Immunoblotting studies were carried out as described in Fig. 3. Saturating amounts of anti-GLUT 1 Ab and 125I-protein A were used in these studies. The 
amount of 125I-protein A associated with the GLUT 1 transporter immuno-complex was determined according to the method described in the text. 
Background counts were subtracted from each determination. Previous studies revealed that the molar content of the GLUT 1 transporter could be 
determined by the maximum binding capacity of the low affinity CB binding site (18.1 pmol per mg protein) in the glucose-grown D23 plasma membrane 
[40]. Knowing this value and the amount of 12Sl-protein A bound to the glucose-grown D23 plasma membrane, GLUT 1 transporter levels in other 
membrane preparations were then calculated. Assuming one CB molecule will bind with one molecule of the GLUT 1 transporter, the amount of CB bound 
should reflect the number of GLUT 1 transporter p esent. 
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was calculated to be 220 pmol/105 cells per min (Fig. 4). 
Similar K m value was also obtained when the data were 
fitted by non-linear egression. The protein content of rat 
myoblasts was previously shown to be around 0.55 mg/106 
cells [13], and 10% of these was associated with the 
plasma membrane [38]. Based on these values, the GLUT 
1 transport capacity of glucose-starved M3 cells was calcu- 
lated to be 40 nmol per mg plasma membrane protein per 
min. This value was very similar to the GLUT 1 trans- 
porter level (44 nmol per mg plasma membrane protein) 
detected by immunoblotting studies with the glucose- 
starved M3 plasma membrane (Table 2). More impor- 
tantly, these studies demonstrated the differences in the 
transport affinity of the GLUT 1 transporter present in 
glucose-grown and -starved cells. 
3.6. Intrinsic property of the activated GLUT 1 transporter 
The observation that the GLUT 1 transporter was the 
only functional GLUT transporter present in glucose- 
starved M1 and M3 mutants allowed an examination of the 
intrinsic property of this transporter without interference 
by other GLUT transporters. CB, phloretin, phlorizin and 
pCMBS are very potent inhibitors for various GLUT trans- 
porters [1]. While these inhibitors were previously shown 
to inhibit dGlc uptake by the glucose-grown M1 and M3 
mutants by about 20% [1], they inhibited dGlc uptake by 
glucose-starved M1 and M3 mutants by about 60% (Table 
3). It is therefore apparent that the intrinsic activity of the 
GLUT 1 transporter in glucose-starved mutants differ con- 
siderably from its glucose-grown counterpart. 
The ability of the glucose-starved M1 and M3 mutants 
to take up MeGlc was also examined. Unlike their dGlc 
uptake properties, the GLUT 1 transporter present in these 
glucose-starved cells exhibited very low transport affinity 
for MeGlc (Fig. 5). Analysis by non-linear regression 
revealed that the apparent K m values of the glucose-starved 
D23, M1 and M3 myoblasts were 4.4 __+ 0.6 mM, 15.9 + 1.7 
mM and 12.8___ 2.5 mM, respectively. Transport studies 
using much higher MeGlc concentrations also revealed 
that the apparent g m value for MeGlc uptake was around 
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Fig. 5. Kinetics of 3-O-methylglucose uptake by glucose-starved M1 and 
M3 mutants and their parental D23 myoblast. Transport studies were 
carried out with glucose-starved cells as described in the text. Initial rates 
of uptake (V) were calculated from the amount of MeGlc taken up at 
23 ° C in 15, 30, 45, and 60 s. The velocity is expressed as pmol of MeGlc 
taken up per min per 105 cells. S refers to the concentration f MeGlc (in 
mmoles per litre) used. An equal amount of counts was added to each 
MeGIc concentration. Data were analyzed by Lineweaver-Burk plot. O, 
zx, and v denote uptake by glucose-starved D23, M1 and M3 cells, 
respectively. The lines through the symbols were drawn by a linear least 
squares regression fit program (SlideWrite Plus T M  , version 4.0, Advanced 
Graphics Software, Sunnyvale, CA). 
10 mM (data not shown). Thus, similar to findings using 
the Xenopus oocyte expression system, MeGlc was a poor 
substrate for the GLUT 1 transporter [5]. 
The effect of o-galactose on dGlc uptake was also 
examined. Analysis of the data by Dixon plot revealed that 
D-galactose was a poor inhibitor for dGlc uptake by glu- 
cose-starved M1 and M3 cells, but not for L6 cells (Fig. 
6). Inhibition of dGlc uptake by glucose-starved M1 and 
M3 cells could not be observed when transport assays 
were carried in the presence of 3 mM o-galactose. Thus, 
unlike the GLUT 3 and GLUT 4 transport processes [31], 
D-galactose was a poor substrate for the rat myoblast 
GLUT 1 transporter. Studies with the Xenopus oocyte 
Table 3 
Effects of specific hexose transport inhibitors on dGlc uptake by rat myoblast mutants 
Cultures Glucose dGlc uptake by Cytochalasin B Phloretin Phlorizin pCMBS 
transporter untreated cells (3/xM) (10/xM) (30 ~M) (2 mM) 
isoforms (pmol/105 
cells per min) 
Glucose-grown L6 GLUT 3/4  11.42 (100%) 26% 33% 61% 43% 
Glucose-grown D23 GLUT 4 4.22 (100%) 0% 0% 5% 10% 
Glucose-starved M1 GLUT 1 18.52 (100%) 50% 52% 65% 50% 
Glucose-starved M3 GLUT 1 15.72 (100%) 36% 44% 57% 37% 
Day 2 subconfluent cultures were used in these studies. Transport studies were carried out as described in the text. The concentration f dGlc used was 
0.06 mM. lnhibitors were added at time zero. Samples were taken at 15, 30, 45, and 60 s. The amount of dGlc internalized via simple diffusion (as 
determined by the rate of dGlc uptake by the cytochalasin B-treated D23) was subtracted from the raw data [1]. Results were expressed as percentages of 
untreated cells. Data were the means of three independent experiments, with an average rror of 5%. 
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Fig. 6. Effect of D-galactose ort 2-deoxy-D-glucose uptake by glucose- 
starved M1 and M3 mutants. Transport studies were carried out as 
described inthe text. Initial rates of uptake (V) were calculated from the 
amount of dGlc taken up at 23 ° C in 15, 30, 45, and 60 s. The velocity 
(V) is expressed aspmol of dGlc taken per min per 1.105 cells. The 
effect of D-galactose ondGlc uplake by glucose-starved L6 (O), M1 (•)  
and M3 (•)  mutants was analyzed by Dixon plot. The filled and open 
symbols denote uptake of 0.1 mM and 0.4 mM dGlc, respectively. The 
K i value of D-galactose ondGlc uptake by L6 myoblasts was 4.5 mM. 
expression system also indicated that D-galactose was a 
poor substrate for the GLUT 1 transporter [5]. 
4. D iscuss ion 
The regulation and properties of glucose transporters 
(GLUT) have been examined in a number of cell types 
[2-7,50,62-67]. At least seven different GLUT isoforms 
have been identified. The fact that two or more of these 
isoforms are found in each cell type [6] makes it difficult 
to determine the identity, regulation, property and func- 
tional states of a specific GLUT transporter. The present 
investigation examined the expression and intrinsic prop- 
erty of the GLUT 1 isoform using two independent sponta- 
neous rat myoblast mutants, M1 and M3. The following 
findings indicate that the,~e mutants are ideally suited for 
these studies. (i) Both mutants possessed very high levels 
of the GLUT 1 transcript and transporter (Tables 1 and 2, 
Fig. 3). (ii) They were devoid of the GLUT 2 isoform [1]. 
(iii) They possessed less than 15% of the L6 GLUT 3 
transcript and transporter (Table 1, [1]), and were devoid 
of the GLUT 3 transport activity (Fig. 4). (iii) They 
exhibited no detectable GLUT 4 transport activity (Figs. 4 
and 5), even though they harboured about 24% of the L6 
GLUT 4 transcript and transporter levels (Table 1, [1]). 
(iv) The absence of the GLUT 3 and 4 transport processes 
in these mutants was corroborated by studies using potent 
glucose transport inhibitors and sugar analogues ([1], Fig. 
6). (v) The GLUT 5 isoform was not likely responsible for 
the CB-sensitive dGlc transport activity observed in the 
glucose-starved M1 and M3 mutants (Fig. 4 and Table 3). 
This was because the GLUT 5 transporter could not take 
up dGlc and was insensitive to CB treatment [5]. (vi) 
Finally, the GLUT 1 transcript level in the glucose-starved 
M1 and M3 mutants was 14-times higher than those of 
GLUT 3 and 4 (Table 1 and Fig. 2B). It may be apparent 
that these mutants can serve as unique tools for examining 
the in situ expression, and property of the GLUT 1 isoform 
without interference by other GLUT isoforms. 
GLUT 1 expression is subject to different types of 
negative regulation. First, GLUT 1 expression is influ- 
enced by the presence of the GLUT 4 isoform. GLUT 4- 
mutants possessed twice the amount of GLUT 1 transcript 
present in the isogenic GLUT 4 + L6 and D23 myoblasts 
(Table 1). The GLUT 1 transporter content in the GLUT 
4-  plasma membranes and microsomes was also higher 
than that in D23 and L6 myoblasts (Table 2 and Fig. 3). 
Since M1 and M3 are two independent spontaneous mu- 
tants selected from D23 myoblasts, the increase in GLUT 
1 expression is probably associated with the absence of the 
GLUT 4 isoform in these two mutants. The inverse rela- 
tionship between the GLUT 1 and 4 isoforms was also 
observed in myogenesis-competent and -impaired L6 my- 
oblasts. For example, the L6 myotube GLUT 4 and GLUT 
1 transcripts were 7500% and 25% of the respective day 2 
levels (Fig. 1 and [1]). Inhibition of myogenesis resulted in 
a reduced increase in GLUT 4 transcript and a reduced 
decline in the GLUT 1 transcript (Fig. 1 and [1]). The 
inverse relationship between these two isoforms was also 
observed in other cell types undergoing developmental and 
physiological changes [55,68-70] or treated with insulin, 
cAMP, tumor necrosis factor or monokines [61,71-73]. An 
alternative xplanation is that both M1 and M3 mutants are 
defective in a regulatory element, tentatively referred to as 
the R factor, which can regulate the expression of the 
GLUT 1 and 4 isoforms in opposite ways. We are cur- 
rently examining this possibility by transfecting the M3 
mutant with the GLUT 4 eDNA. 
Second, GLUT 1 expression was reduced during myo- 
genic differentiation (Fig. 1). The GLUT 1 transcript level 
in multinucleated myotubes (day 6 culture) was about 25% 
of that present in day 2 culture; the major decline occurred 
only upon the appearance of myotubes (i.e., between days 
4 and 5) (Fig. 1). This dramatic reduction was not ob- 
served in cells impaired in myogenesis; 40% and 70% of 
the day 2 GLUT 1 transcript level were detected in day 5 
culture of myogenesis-competent and -impaired cells, re- 
spectively. Two lines of evidence indicate that the GLUT 1 
transcript level is altered as a result of changes in the 
GLUT 4 isoform, and not a direct result of myogenesis. (i) 
During growth, a 4-fold increase in the GLUT 4 transcript 
(day 3.5) was detected before the major decline of the 
GLUT 1 transcript (i.e., between day 4 and 5) (Fig. 1, [1]). 
Similar temporal order of expression was also observed in 
adipose tissues [61]. (ii) While the level of the GLUT 1 
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isoform differed considerably between the GLUT 4-  mu- 
tants (M1 and M3) and their parental GLUT 4 + D23 cells, 
all three clones were impaired in myogenesis [44]. This 
clearly indicated the difference in GLUT 1 isoform was 
independent of the cells' ability to undergo myogenesis. 
Thus, while GLUT 4 expression is regulated uring myo- 
genesis, GLUT 1 expression is directly affected by GLUT 
4. 
Third, immunoblotting studies revealed that the GLUT 
1 transporter level in the plasma membrane and micro- 
somes of the GLUT 3 myoblasts (D23 and M3) was 
higher than predicted by their GLUT 1 transcript level 
(Table 1 and 2; Fig. 3). This suggested that the translation 
and/or stability of the GLUT 1 transporter was affected 
by the GLUT 3 isoform. Fourth, GLUT 1 expression was 
negatively regulated in confluent cultures. When compared 
with cultures seeded at 0.2.10 2 cells/cm 2, about 60% 
reduction in the GLUT 1 transcript level was observed in 
day 2 cultures eeded at 0.8- 102 cells/cm 2. 
GLUT 1 expression is subject to positive regulation in 
glucose-starved myoblasts. First, both GLUT 1 transcript 
and transporter levels, but not those of the GLUT 3 and 4 
isoforms, were increased by about 2-fold in glucose-starved 
myoblasts (Tables 1 and 2; Fig. 3). This was similar to L6 
multinucleated myotubes [2,18,22] and rat kidney cells 
[74]. Mutant studies indicated that this glucose starvation- 
mediated increase was mediated by processes independent 
of the GLUT 3 and 4 isoforms (Tables 1 and 2). Thus, the 
synthesis and/or stability of the GLUT 1 isoform are 
positively regulated in glucose-starved cells. 
Second, an examination of the GLUT 1 transport affini- 
ties and responses to inhibitors revealed that the intrinsic 
activity of this transporter was dramatically altered in 
glucose-starved cells. Analysis of transport data by linear 
and non-linear egression programs revealed that dGlc was 
taken up by glucose-grown M1 and M3 myoblasts either 
via an extremely inefficient transporter, or via simple 
diffusion (Fig. 4), despite the relatively high GLUT 1 
transporter level (22 pmol /mg protein) detected in their 
plasma membrane (Table 2). In contrast, the GLUT 1 
transporter in glucose-starved cells took up dGlc with an 
apparent K m value of around 0.9 mM (Fig. 4). This 
transporter also differed from its glucose-grown counter- 
part in its responses to cytochalasin B, phloretin, phlorizin, 
and pCMBS (Table 3). This indicated that the functional 
state and intrinsic property of the GLUT 1 transporter were 
altered by events associated with glucose starvation. Simi- 
lar to findings using the Xenopus oocyte expression sys- 
tem [5], both MeGlc and D-galactose were relatively poor 
substrates for the GLUT 1 transporter present in glucose- 
starved myoblasts (Figs. 5 and 6). 
The GLUT 1 intrinsic activity in other cell types was 
also affected by its immediate nvironment, and was acti- 
vated under a number of conditions. For example, even 
though 3T3-L1 adipocytes contained 30 fold more cell 
surface GLUT 1 transporter than CHO cells, they exhibited 
only 41% of the CHO GLUT 1 transport activity [19]. 
Human GLUT 1 expressed in 3T3-L1 cells also had a 
lower intrinsic activity than when expressed in CHO cells 
[75]. The GLUT 1 intrinsic activity in 3T3-L1 fibroblasts 
was significantly reduced upon differentiation into 
adipocytes, even though the latter possessed 2.6-times 
more cell surface GLUT 1 transporter. Activation of dGlc 
uptake by glucose-grown 3T3-L1 adipocytes, rat adipocytes 
and clone 9 cells by cholera toxin, protein synthesis in- 
hibitors, energy poisons and cadmium was found to be 
mediated by changes in the GLUT 1 intrinsic activity, 
without increasing the level of the cell surface GLUT 1 
transporter [3,75-78]. The GLUT 1 transporter was proba- 
bly catalytically inert under basal conditions, even though 
it was immunoactive in the plasma membrane. These 
cryptic transporters could be activated by mechanisms 
involving protein-protein teraction, covalent or noncova- 
lent modifications of transporters, or changes in their 
microenvironment. 
The rat myoblast GLUT 1 transporter in glucose-grown 
cells may also exist in a cryptic form, which can be 
activated by events associated with glucose starvation. 
Increases in basal dGlc uptake activity were also observed 
when glucose-grown myoblasts were treated with 2,4-di- 
nitrophenol for 24 h [31]; however, increases in transport 
activity could not be detected when glucose-starved cells 
were used instead. In other words, further activation could 
not be achieved once the GLUT 1 transporter has been 
activated by glucose starvation. 
In summary, this study showed that the expression of 
the rat myoblast GLUT 1 transporter was subject o differ- 
ent types of regulation. Studies with mutants defective in 
GLUT 3 and/or GLUT 4 provided valuable information 
not only on the in situ regulation of GLUT 1 expression, 
but also on the intrinsic property of the GLUT 1 trans- 
porter. 
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